Physician profile
Mark B Privott
NPI 1164416343
$1,744.12
in general payments reported to CMS, 2019-2025
14 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2021: $506 · 2022: $249 · 2023: $121 · 2024: $291 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517 · Entertainment: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.50 |
| Entertainment | $202.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $352.82 | 2021-2024 | Ce-Marked Kxla System |
| Johnson & Johnson Vision Care, INC. | $272.16 | 2021-2025 | Acuvue |
| Optos, INC. | $202.41 | 2023-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $179.11 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $166.51 | 2019 | |
| Kala Pharmaceuticals, INC. | $120.36 | 2021 | |
| Dompe US, INC. | $117.11 | 2022 | |
| Allergan, INC. | $105.67 | 2022 | |
| Coopervision INC. | $74.43 | 2024 | Myday Contact Lens |
| Alcon Vision LLC | $51.16 | 2024-2025 | Total30 |
| Staar Surgical Company | $31.14 | 2019 | |
| Abbvie INC. | $28.57 | 2023 | |
| Bausch & Lomb Americas INC. | $24.81 | 2024 | Infuse, Biotrue One Day |
| Johnson & Johnson Surgical Vision, INC. | $17.86 | 2023 | Tecnis Simplicity, Tecnis Iol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Privott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.